Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;4(10):1331-1334.
doi: 10.1038/s43587-024-00719-8.

SEA-AD is a multimodal cellular atlas and resource for Alzheimer's disease

Affiliations

SEA-AD is a multimodal cellular atlas and resource for Alzheimer's disease

Michael Hawrylycz et al. Nat Aging. 2024 Oct.

Abstract

The Seattle Alzheimer’s Disease Brain Cell Atlas (SEA-AD) is a multifaceted open data resource designed to identify cellular and molecular pathologies that underlie Alzheimer’s disease. Integrating neuropathology, single cell and spatial genomics, and longitudinal clinical metadata, SEA-AD is a unique resource for studying the pathogenesis of Alzheimer’s and related dementias.

PubMed Disclaimer

Conflict of interest statement

Competing interests

The authors declare no competing interests.

Figures

Fig. 1|
Fig. 1|. SEA-AD project study design.
SEA-AD workflow integrates molecular standards, image-based neuropathology, clinical metadata and modeling of disease trajectory to produce a new atlas of AD. a. Donor selection through ADRC and ACT enables a multiregion profile across a diverse cohort. b. Machine-learning automated tissue parcellation and quantification. c. Neuropathology and molecular characterization using single-cell methods, d. Statistical modeling of continuous pseudo-time disease severity and progression, e. Brain-wide single-cell molecular atlases developed through BICAN provide a framework for comparison and analysis in AD. f, BICAN taxonomy is expanded to include disease-modified cell types for further study. Astro, astrocyte; CPS, continuous pseudo-progression score; CT, corticothalamic; endo, endothelial; ET, extratelencephalic; IT, intratelencephalic; micro, microglia; oligo, oligodendrocyte; NP, near- projecting; OPC, oligodendrocyte precursor cell; PVM, perivascular macrophage; snRNA-seq, single-nucleus RNA sequencing; VLMC, vascular leptomeningealcell.
Fig. 2|
Fig. 2|. SEA-AD data portal and resources.
a-f, Resources and tools available through the SEA-AD portal enable users to: view donor metadata and neuropathology images (a); perform comparative analysis of molecular differences in disease state (b); investigate molecular changes within cell types with respect to neuropathology and pseudotime progression (c); integrate with the Allen Brain Cell Atlas for whole-brain single-cell expression and spatial transcriptomics (d); use the MapMyCells tool for mapping user data to the BICAN standard atlas in the MTG (e); have access to data, summaries and documentation with links to external resources through Sage Bionetworks AD Knowledge Portal, Open Data on AWS and SEA-AD.org (f).

References

    1. 2023 Alzheimer’s disease facts and figures. Alzheimers. Dement 19, 1598–1695 (2023). - PubMed
    1. Masters CL et al. Alzheimer’s disease. Nat. Rev. Dis. Primers 1, (2015). - PubMed
    1. Jack CR, Jr et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 9, 119–128 (2010). - PMC - PubMed
    1. van Dyck CH et al. Lecanemab in early Alzheimer’s disease. N. Engl. J. Med. 388, 9–21 (2023). - PubMed
    1. BRAIN Initiative Cell Census Network (BICCN). A multimodal cell census and atlas of the mammalian primary motor cortex. Nature 598, 86–102 (2021). - PMC - PubMed

LinkOut - more resources